About Us

Grace Bay Capital provides seed funding to companies delivering breakthroughs at the intersection of biology, the physical sciences, material science, engineering, and artificial intelligence. We are operators from the life sciences industry who understand the ecosystem and its driving forces. Our aim is to reimagine how humans and machines work together to transform and accelerate scientific discovery.  We believe that over time this will lower development and production costs and increase global access to medicine and life-saving therapies.

Instruments, Diagnostics, & Software

Precision tools that enhance data accuracy and lab efficiency in life sciences.

Material Science Innovations

Supporting breakthroughs in novel materials that improve machine sensitivity and performance.

Physical AI Integration

AI-driven systems that automate complex lab workflows and accelerate research outcomes.

Next-Gen Lab Automation

Scalable intelligence that reduces biopharma discovery costs through increased productivity.